Is a
Patent attributes
Patent Applicant
Patent Jurisdiction
Patent Number
Date of Patent
November 23, 2021
Patent Application Number
17212425
Date Filed
March 25, 2021
Patent Primary Examiner
Patent abstract
Provided are compounds that target plexin domain containing 2 (PLXDC2). The compounds can be used to treat conditions such as inflammatory or immune-mediated diseases, diabetes, infectious diseases, and cancers. The compounds can be used to treat such specific conditions as systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, autoimmune encephalitis, diabetic nephropathy, diabetic retinopathy, psoriasis, and inflammatory bowel disease, among other conditions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
